Scalar Bioscience Information

Scalar Bioscience develops products and technologies that improve the quality of life for patients and efficiency of healthcare access and delivery. Founded in 2001 as Sensory Arts & Science, the company has successfully commercialized offerings in the hearing care market, and we have several promising technologies in vision and hearing science as well as telehealth and communications. In 2016 we changed the company name to Scalar Bioscience to reflect the broadening of our efforts and portfolio of companies and technologies into areas beyond diagnostics to include therapeutics. Our prevention and early intervention approach helps ensure better patient outcomes, reduced incidence, and efficiency in care delivery. Our principal objective is to develop:Products and tools for managing the occurrence, severity, and duration of certain targeted health and wellness issues;In conjunction with healthcare experts and opinion leaders, and peer reviewed by key industry participants;Whose value proposition involves early intervention, thereby reducing incidence and cost, and improving outcomes and efficiency in patient care delivery. We strive to create technologies and products that address important and unmet needs in diseases and conditions that affect broad population segments, thereby creating sustainable value for our stakeholders and partners.